NeuroSense Therapeutics Ltd.
Developing combination therapies for neurodegenerative diseases, with a focus on ALS.
NRSN | NDAQ
Overview
Corporate Details
- ISIN(s):
- IL0011809592 (+1 more)
- LEI:
- Country:
- United States of America
- Address:
- 11 HAMENOFIM ST., 4672562 HERZLIYA
- Website:
- https://www.neurosense-tx.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
NeuroSense Therapeutics is a late-stage clinical biotechnology company focused on discovering and developing innovative therapeutics for neurodegenerative diseases, with a primary emphasis on amyotrophic lateral sclerosis (ALS). The company's core strategy is to create combined therapies that target multiple underlying pathological mechanisms of these complex conditions. Its lead drug candidate, PrimeC, is a novel fixed-dose combination therapy developed for ALS. PrimeC has successfully completed a Phase 2b clinical trial, demonstrating a significant impact on slowing disease progression, and has received orphan drug designation from the U.S. FDA and the EMA. NeuroSense is currently advancing PrimeC into a pivotal Phase 3 study and preparing for potential commercialization.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all NeuroSense Therapeutics Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for NeuroSense Therapeutics Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for NeuroSense Therapeutics Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
